These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Albumin-Binding Fatty Acid-Modified Gapmer Antisense Oligonucleotides for Modulation of Pharmacokinetics. Cai Y; Lou C; Wengel J; Howard KA Methods Mol Biol; 2020; 2176():163-174. PubMed ID: 32865790 [TBL] [Abstract][Full Text] [Related]
5. Hsp90 protein interacts with phosphorothioate oligonucleotides containing hydrophobic 2'-modifications and enhances antisense activity. Liang XH; Shen W; Sun H; Kinberger GA; Prakash TP; Nichols JG; Crooke ST Nucleic Acids Res; 2016 May; 44(8):3892-907. PubMed ID: 26945041 [TBL] [Abstract][Full Text] [Related]
6. Evaluating the Knockdown Activity of MALAT1 ENA Gapmers In Vitro. Iwashita S; Shoji T; Koizumi M Methods Mol Biol; 2020; 2176():155-161. PubMed ID: 32865789 [TBL] [Abstract][Full Text] [Related]
7. The intratracheal administration of locked nucleic acid containing antisense oligonucleotides induced gene silencing and an immune-stimulatory effect in the murine lung. Uemura Y; Hagiwara K; Kobayashi K PLoS One; 2017; 12(11):e0187286. PubMed ID: 29107995 [TBL] [Abstract][Full Text] [Related]
8. Synthesis of multivalent fatty acid-conjugated antisense oligonucleotides: Cell internalization, physical properties, and in vitro and in vivo activities. Tanaka Y; Tanioku Y; Nakayama T; Aso K; Yamaguchi T; Kamada H; Obika S Bioorg Med Chem; 2023 Mar; 81():117192. PubMed ID: 36780806 [TBL] [Abstract][Full Text] [Related]
9. Mouse genome-wide association studies and systems genetics uncover the genetic architecture associated with hepatic pharmacokinetic and pharmacodynamic properties of a constrained ethyl antisense oligonucleotide targeting Malat1. Pirie E; Ray S; Pan C; Fu W; Powers AF; Polikoff D; Miller CM; Kudrna KM; Harris EN; Lusis AJ; Crooke RM; Lee RG PLoS Genet; 2018 Oct; 14(10):e1007732. PubMed ID: 30372444 [TBL] [Abstract][Full Text] [Related]
10. Characterization of the Prion Protein Binding Properties of Antisense Oligonucleotides. Reidenbach AG; Minikel EV; Zhao HT; Guzman SG; Leed AJ; Mesleh MF; Kordasiewicz HB; Schreiber SL; Vallabh SM Biomolecules; 2019 Dec; 10(1):. PubMed ID: 31861275 [TBL] [Abstract][Full Text] [Related]